Inovio Biomedical Corporation, a leader in DNA vaccine design, evolution and delivery, announced today that the company was awarded a Vaccine megacorp* Excellence Award in the category of "Best Early Stage Biotech" by a panel of judges be an element of of a broad eclecticism of biotech manufactory stakeholders. The award was presented at the World Vaccine senate being held April 19 - 22, 2010, in Washington, D.C.

More: - Brought to my attention by